Related Experiment Videos
[A biodistribution experiment on 125 I-VIP in mice]
Hua Xi Yi Ke Da Xue Xue Bao = Journal of West China University of Medical Sciences = Huaxi Yike Daxue Xuebao
|February 23, 2000
Summary
This study tracked 125I-vasoactive intestinal peptide (VIP) in mice, finding it concentrates in lungs and is cleared by kidneys. VIP itself inhibits uptake, suggesting receptor-mediated distribution for potential tumor imaging.
Area of Science:
- Nuclear medicine
- Radiopharmacology
- Pharmacokinetics
Context:
- Vasoactive intestinal peptide (VIP) plays roles in various physiological processes.
- Understanding the biodistribution of radiolabeled VIP is crucial for developing targeted imaging agents.
- Previous studies have explored VIP's functions, but detailed biodistribution data for imaging applications is needed.
Purpose:
- To investigate the biodistribution characteristics of high specific activity 125I-vasoactive intestinal peptide (VIP) in normal mice.
- To evaluate the effect of unlabeled VIP on the distribution of 125I-VIP.
- To assess the potential of 125I-VIP as an imaging agent for gastrointestinal tumors.
Summary:
- 125I-VIP rapidly distributed to the lungs, with elimination primarily through the kidneys.
- The half-life of 125I-VIP in blood was less than 20 minutes.
- Unlabeled VIP demonstrated dose-dependent inhibition of 125I-VIP uptake in lungs, liver, and intestines, indicating VIP receptor-mediated distribution.
Impact:
- The biodistribution profile of 125I-VIP, with lung accumulation and renal clearance, is informative for developing radiotracers.
- The findings support the potential use of 131I or 123I-labeled VIP for imaging gastrointestinal tumors.
- This research provides a foundation for further development of VIP-based radiopharmaceuticals.